Sophie Lanzkron, MD
Professor of Medicine and Oncology
Johns Hopkins School of Medicine
1830 E Monument Street, Suite 7300
Baltimore, MD 21205
Email: slanzkr@jhmi.edu

Dr. Sophie Lanzkron is a Professor of Medicine and Oncology at Johns Hopkins University School of Medicine. Dr. Lanzkron is a hematologist and Director of the Sickle Cell Center for Adults. She received her BA from Brandeis University and graduated from the Albert Einstein College of Medicine where she was inducted into the AOA honor society. She did her residency at the University of Maryland and her hematology fellowship at Hopkins. She is internationally recognized for her pioneering research on the optimal care and management of patients with sickle cell disease. She has served on the National Institutes of Health, Expert Panel in the Management of Sickle Cell Disease and on the American Society of Hematology’s Sickle Cell Guideline Panel. She is co-Chair of the Clinical Trial Sub-committee for the NIH’s Cure Sickle Cell Initiative and Chair of the American Society of Hematology’s Clinical Trial Network’s Patient Engagement Committee. Her research focus is on improving the quality of care provided to this historically underserved population and she is considered an expert in health services research in sickle cell disease. She takes pride in the successes of her mentees, her husband Daniel and her two sons Benjamin and Eli.

Dr. Sophie Lanzkron has served as a Non-CE Consultant for Nova-Nordisk, Novartis, Bluebird Bio, and Pfizer. She has done Contract Research for GBT, Site PI: Novartis, Shire, Imara. She owns stocks of the CI as she is a trustee for her parents trust with Pfizer and Teva stocks.